04/11/2024
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:09 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEFA14A | |
04/11/2024
3:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form ARS | |
04/01/2024
5:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
5:21 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
03/21/2024
4:02 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
|
03/21/2024
4:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/02/2024
3:32 PM | BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
01/31/2024
11:11 AM | Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D | |
01/24/2024
6:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:55 PM | Avidity Partners Management LLC (0001993910) (Reporting)
Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Gregory Michael David (Reporting)
Meng Lei (Reporting)
Witzke David Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
4:26 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/22/2024
6:34 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:02 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
11/13/2023
8:02 AM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
10/25/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:55 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/28/2023
4:09 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
| Form SC 13D | |
09/21/2023
3:23 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
3:32 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
09/21/2023
3:15 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
09/21/2023
3:15 PM | 5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
09/20/2023
8:50 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K/A | |
09/15/2023
3:56 PM | Atlas Venture Fund X, L.P. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2023
8:56 PM | Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Meng Lei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:31 PM | Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Meng Lei (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:45 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:46 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:46 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:47 PM | CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:48 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:50 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:51 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:52 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
7:55 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/13/2023
8:13 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new way to collect income from stocks (Ad) Most people think of BUYING options when they talk about options.
It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
The problem is - they don’t always pay off when you buy them.
In fact, a contributing writer at the Financial Post studied options extensively…  Click here to see me place one of these trades LIVE on camera. |
09/13/2023
8:14 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:16 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:17 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:17 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
8:25 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:19 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
8:00 AM | Magenta Therapeutics, Inc. (Subject)
Dianthus Therapeutics (Subject)
| Form 425 | |
08/03/2023
7:01 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
11:15 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
08/01/2023
3:42 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 424B3 | |
07/17/2023
8:30 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form S-4/A | |
06/22/2023
4:23 PM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form S-4/A | |
05/15/2023
7:39 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
05/03/2023
6:59 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 8-A12B | |
05/03/2023
6:44 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
6:47 AM | Magenta Therapeutics, Inc. (Subject)
Dianthus Therapeutics (Subject)
| Form 425 | |
05/01/2023
7:31 AM | Magenta Therapeutics, Inc. (Filer)
Dianthus Therapeutics (Filer)
| Form 10-K/A | |
